FindTrial
Sign In

Passive Transmission of COVID-19 Antibody From Mother to Infant

Passive Transmission of COVID-19 Antibody From Mother to Infant

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300072944
Enrollment
Unknown
Registered
2023-06-28
Start date
2022-10-19
Completion date
Unknown
Last updated
2023-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Passive transmission of maternal antibodies

Interventions

experiment group:none
control group:none

Sponsors

Children's hospital of chongqing medical university
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 1.5 Years

Inclusion criteria

Inclusion criteria: a. Children aged 0-15; b. No history of blood transfusion, chemotherapy, or related immunosuppressive therapy; No immune system related diseases;

Exclusion criteria

Exclusion criteria: N/A

Design outcomes

Primary

MeasureTime frame
IgG;neutralizing antibody;—

Secondary

MeasureTime frame
IgG subclass;—

Countries

china

Contacts

Public ContactYuting Yang

Children's hospital of chongqing medical university

412384223@qq.com+86 189 9030 4808

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026